Five companies added to MSCI India Index; four deleted

Published On 2020-05-17 04:30 GMT   |   Update On 2020-05-17 04:30 GMT
Advertisement

New Delhi: A total of four companies, including Ashok Leyland and Tata Power Company, have been removed from the MSCI India Index, while there have been five additions, it said in a statement.

While four companies -- Ashok Leyland, Tata Power Company, Shriram Transport Finance Company and Mahindra & Mahindra Financial Services -- have been deleted from the MSCI India Index, five firms have been added to the list, the index compiler said.

Advertisement

The changes in constituents for the MSCI Global Standard Indexes will take place as of the close of May 29, 2020, it said.

The five additions to the MSCI India Index are Biocon, Indraprastha Gas Limited, Jubilant Foodworks, Tata Consumer Products and Torrent Pharmaceuticals.

MSCI Global Standard Index is widely used by global fund houses for benchmarking global equities portfolios.

The changes were announced by MSCI in its semi-annual index review of the global investable market indexes May 2020.

In the small-cap index, 18 companies have been added, while there have been 54 deletions.

Among those added are Bharat Heavy Electricals and JB Chemicals & Pharmaceuticals, while Adani Transmission, BEML, Ashoka Buildcon and Dish TV India among others are deleted.

Read also: Torrent Pharma, Biocon candidates for MSCI Index: Morgan Stanley


Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News